Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
8.25
+0.07 (0.86%)
At close: Dec 20, 2024, 4:00 PM
8.27
+0.02 (0.24%)
After-hours: Dec 20, 2024, 7:53 PM EST

Altimmune Revenue

Altimmune had revenue of $5.00K in the quarter ending September 30, 2024, a decrease of -98.62%. This brings the company's revenue in the last twelve months to $52.00K, down -81.36% year-over-year. In the year 2023, Altimmune had annual revenue of $426.00K, down -726.47%.

Revenue (ttm)
$52.00K
Revenue Growth
-81.36%
P/S Ratio
n/a
Revenue / Employee
$881
Employees
59
Market Cap
586.78M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023426.00K494.00K-726.47%
Dec 31, 2022-68.00K-4.48M-101.54%
Dec 31, 20214.41M-3.78M-46.12%
Dec 31, 20208.19M2.38M41.09%
Dec 31, 20195.80M-4.53M-43.85%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cross Country Healthcare 1.45B
Varex Imaging 811.00M
Fulgent Genetics 277.76M
Surmodics 126.08M
GRAIL 117.67M
Simulations Plus 70.01M
Capricor Therapeutics 23.23M
Revenue Rankings